Catherine Droitcourt
Catherine Droitcourt is an expert in Dermatology at Centre Hospitalier Universitaire de Rennes (France). As of October 2026, ScienceLeadR ranks Catherine Droitcourt in the top 1% of experts worldwide for Dermatitis, Hypersensitivity and Skin Diseases, Genetic. Catherine Droitcourt has authored 209 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 5 of them ongoing. SLR score: 706 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Immunology - Pediatrics - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 209
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Correction: Effectiveness and Safety of IL‑17A Inhibitors in Pediatric Psoriasis: A Real‑World, Multicenter, International Study. PMID 42870136 — safety, pharmaceutical preparations, psoriasis | Paediatr Drugs | 2026 | 0 |
| A New Phototherapy Regimen Coupled with Oral Vitamin D Supplementation, for the Long-Term Control of Atopic Dermatitis: A French Multicenter, Randomized, Crossover, Pragmatic Trial. PMID 42728529 — vitamin d, dermatitis, vitamins, phototherapy, genes, tat, therapeutics, dermatitis, atopic | Dermatol Ther (Heidelb) | 2026 | 0 |
| Major adverse cardiovascular events in atopic dermatitis treated with Janus kinase inhibitors. PMID 42712086 — sexually transmitted diseases, dermatitis, skin diseases, janus kinases, janus kinase inhibitors, pharmacoepidemiology, dermatitis, atopic | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Neurological complications associated with EMONO in patients with epidermolysis bullosa. PMID 42417492 — sexually transmitted diseases, skin diseases, epidermolysis bullosa, subacute combined degeneration | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Real-World Systemic Treatment Patterns and Outcomes of Children With Severe Alopecia Areata: A French Nationwide Study (ESTAPED ohort). PMID 42348162 — dermatitis, alopecia areata, pharmaceutical preparations, adrenal cortex hormones, maintenance, therapeutics, methotrexate, child, alopecia, dermatitis, atopic | Paediatr Drugs | 2026 | 0 |
Clinical Studies 15
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate to Severe Atopic Dermatitis 2023-508235-31-00 — safety, dermatitis, signs and symptoms, adolescent, therapeutics, dermatitis, atopic | Phase 3 | Active not recruiting | 2024 |
| Acetylsalicylic Acid Versus Placebo as an add on Treatment to Local Non steroidal Anti inflammatory Drug for the Management of Thrombotic Episodes in Superficial Venous Malformations in Children Aged 6 to 17 Years NCT07663825 — pharmaceutical preparations, venous thrombosis, aspirin, anti-inflammatory agents, non-steroidal, aged, diclofenac, therapeutics, thrombosis, child | Phase 2 | Not yet recruiting | 2026 |
| Dupilumab step down strategy to maintain remission in adult and adolescents patients with atopic dermatitis a non inferiority randomized trial 2022-501179-23-00 — dermatitis, adolescent, dermatitis, atopic | Phase 4 | Active not recruiting | 2023 |
| Study of Alloknesia in Atopic Dermatitis NCT06923202 — touch, dermatitis, skin diseases, pruritus, dermatitis, atopic | N/A | Recruiting | 2026 |
| CongenItal Naevus Cohort for Longitudinal Evaluation NCT06828822 — skin, quality of life, parturition, melanoma, brain, neurodevelopmental disorders, therapeutics, nevus, child, neurodevelopment | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map